Meet the next generation of consumers where they are now. Join us virtually for The New Consumer, on March 30, for tips from Clutch, Mars Wrigley and more. Sign up for free.
Syfy is hungry for a scripted hit. It’s not for a lack of trying. While Defiance, a huge wager on transmedia content, put up decent if unspectacular ratings during its premiere run, the network’s top earners continue to be a mixed bag of WWE (Friday Night Smackdown), reality (FaceOff, Ghost Hunters) and its signature original films (Sharknado). For all that, Syfy’s 2013 prime-time demo deliveries fell 11 percent. With genre shows more popular than ever, there may be no better time for the network to roll the dice on a fleet of high-concept drama series.
Enter Helix, a CDC/outbreak thriller that’s as compelling as anything Syfy’s done.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in